Press
·
News
POELLATH advises investor consortium on acquisition of amedes Group
OMERS and Goldman Sachs each acquired 37.5 percent and AXA 25 percent of amedes.
Amedes performs more than 400,000 medical analyses daily for the healthcare industry in its 75+ laboratories and specialized medical sites in Germany, Belgium and Austria. Under the ownership of the investor consortium, amedes will further expand its leading market position in integrated specialty diagnostics, particularly in the areas of gynecology, endocrinology and fertility medicine. Other growth areas include genetics, rheumatology and oncology.
POELLATH provided legal and tax advice to the investor consortium regarding management participation with the following team:
- Dr. Barbara Koch-Schulte (partner, M&A, private equity, tax law, Munich)
- Lorena Joana Echarri (counsel, M&A, private equity, tax law, Munich)
Contact
